PriCoTTF: A phase I/II single-arm trial of tumor treating fields prior and concomitant with radiotherapy and temozolomide in newly diagnosed glioblastoma

被引：0
|
作者：
Glas, M. [1 ]
Scheffler, B. [2 ]
Lazaridis, L. [1 ]
Herrlinger, U. [3 ]
Pierscianek, D. [4 ]
El Hindy, N. [4 ]
Sure, U. [4 ]
Proescholdt, M. [5 ]
Hau, P. [6 ]
Hense, J. [7 ]
Kleinschnitz, C. [8 ]
Combs, S. E. [9 ]
Grosu, A. -L. [10 ]
Stuschke, M. [11 ]
Kebir, S. [1 ]
机构：
[1] Univ Klinikum Essen, Klin Neuroonkol, Essen, Germany
[2] Univ Klinikum Essen, Translat Onkol, Westdeutsch Tumorzentrum, Essen, Germany
[3] Univ Klinikum Bonn, Klin Neuroonkol, Bonn, Germany
[4] Univ Klinikum Essen, Klin Neurochirurg, Essen, Germany
[5] Univ Klinikum Regensburg, Neurochirurg, Regensburg, Germany
[6] Univ Klinikum Regensburg, Neurol NeuroOnkol, Regensburg, Germany
[7] Univ Klinikum Essen, Innere Klin Tumorforsch, Essen, Germany
[8] Univ Klinikum Essen, Neurol Klin, Essen, Germany
[9] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin RadioOnkol & Strahlentherapie, Munich, Germany
[10] Univ Klinikum Freiburg, Klin Strahlenheilkunde, Freiburg, Germany
[11] Univ Klinikum Essen, Klin Strahlenheilkunde, Essen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2018年 / 194卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P02-5
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [21] TIME TO FUNCTIONAL AND COGNITIVE DECLINE IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Nicholas, Garth A.
    Hirte, Holger
    Easaw, Jacob
    Muanza, Thierry
    Roberge, David
    Mathieu, David
    Pitz, Marshall
    NEURO-ONCOLOGY, 2017, 19 : 138 - 138
  • [22] PHASE III TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) TOGETHER WITH TEMOZOLOMIDE (TMZ) COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Farber, Ori
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2013, 15 : 76 - 77
  • [23] RETROSPECTIVE ANALYSIS OF USING RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATING FIELDS FOR CHINESE PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Wang, Yang
    Wu, Jingsong
    Qin, Zhiyong
    Wang, Enmin
    Yao, Yu
    Zhuang, Dongxiao
    Liang, Lipin
    Ni, Chunxia
    Lu, Peijiang
    Chen, Shu
    Li, Chao
    NEURO-ONCOLOGY, 2021, 23 : 72 - 72
  • [24] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Saran, Frank
    Welsh, Liam
    James, Allan
    McBain, Catherine
    Gattamaneni, Rao
    Jefferies, Sarah
    Harris, Fiona
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Cseh, Agnieszka
    Brada, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (03) : 307 - 317
  • [25] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Frank Saran
    Liam Welsh
    Allan James
    Catherine McBain
    Rao Gattamaneni
    Sarah Jefferies
    Fiona Harris
    Karine Pemberton
    Jennifer Schaible
    Shaun Bender
    Agnieszka Cseh
    Michael Brada
    Journal of Neuro-Oncology, 2021, 155 : 307 - 317
  • [26] RANDOMIZED PHASE II TRIAL OF TUMOR TREATING FIELDS PLUS RADIATION THERAPY PLUS TEMOZOLOMIDE COMPARED TO RADIATION THERAPY PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Limon, D.
    Bokstein, F.
    Blumenthal, D.
    Ben Harush, C.
    Ram, Z.
    Grossman, R.
    NEURO-ONCOLOGY, 2019, 21 : 86 - 86
  • [27] PHASE II TRIAL OF SURVAXM PLUS TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Ahluwalia, Manmeet
    Ciesielski, Michael J.
    Reardon, David A.
    Abad, Ajay
    Curry, William
    Wong, Eric
    Peereboom, David
    Figel, Sheila
    Hutson, Alan
    Groman, Adrienne
    Withers, Henry
    Liu, Song
    Belal, Ahmed
    Qiu, Jingxin
    Mogensen, Kathleen
    Schilero, Cathy
    Khosla, Atulya
    Casucci, Danielle
    Mechtler, Laszlo
    Fenstermaker, Robert
    NEURO-ONCOLOGY, 2022, 24 : 66 - 66
  • [28] PROSPECTIVE, MULTI-CENTER PHASE III TRIAL OF TUMOR TREATING FIELDS TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Stupp, Roger
    Idbaih, Ahmed
    Steinberg, David M.
    Read, William
    Toms, Steven
    Barnett, Gene
    Nicholas, Garth
    Kim, Chae-Yong
    Fink, Karen
    Salmaggi, Andrea
    Lieberman, Frank
    Zhu, Jay
    Taylor, Lynne
    Stragliotto, Giuseppe
    Hottinger, Andreas
    Kirson, Eilon D.
    Weinberg, Uri
    Palti, Yoram
    Hegi, Monika E.
    Ram, Zvi
    NEURO-ONCOLOGY, 2016, 18 : 1 - 1
  • [29] EF-32 (TRIDENT): A pivotal phase 3 randomized trial of concomitant radiation therapy and temozolomide plus /- Tumor Treating Fields (TTFields) in newly diagnosed glioblastoma
    Glas, M.
    Kleinberg, L.
    Jeyapalan, S.
    Goldlust, S.
    Nagpal, S.
    Combs, S.
    Roberge, D.
    Nishikawa, R.
    Reardon, D.
    Grossman, R.
    Shi, W.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S97 - S98
  • [30] TUMOR TREATING FIELDS COMBINED WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA: FINAL RESULTS FROM A PILOT STUDY
    Grossman, Rachel
    Limon, Dror
    Bokstein, Felix
    Blumenthal, Deborah
    Ben Harush, Camit
    Ram, Zvi
    NEURO-ONCOLOGY, 2019, 21 : 23 - 24
12345